WO2009016608A3 - Pharmaceutical compositions of fenofibrate - Google Patents
Pharmaceutical compositions of fenofibrate Download PDFInfo
- Publication number
- WO2009016608A3 WO2009016608A3 PCT/IB2008/053091 IB2008053091W WO2009016608A3 WO 2009016608 A3 WO2009016608 A3 WO 2009016608A3 IB 2008053091 W IB2008053091 W IB 2008053091W WO 2009016608 A3 WO2009016608 A3 WO 2009016608A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pharmaceutical compositions
- fenofibrate
- relates
- compositions
- micronized fenofibrate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Abstract
The invention relates to pharmaceutical compositions comprising non-micronized fenofibrate with one or more pharmaceutically acceptable vehicles. The invention also relates to pharmaceutical compositions comprising non-micronized fenofibrate with one or more cyclodextrin derivatives. The invention also relates to processes for the preparation of such compositions.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/671,832 US20100285126A1 (en) | 2007-08-02 | 2008-08-01 | Pharmaceutical compositions of fenofibrate |
EP08789518A EP2190415A2 (en) | 2007-08-02 | 2008-08-01 | Pharmaceutical compositions of fenofibrate |
Applications Claiming Priority (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1487/MUM/2007 | 2007-08-02 | ||
IN1486MU2007 | 2007-08-02 | ||
IN1485MU2007 | 2007-08-02 | ||
IN1488/MUM/2007 | 2007-08-02 | ||
IN1484MU2007 | 2007-08-02 | ||
IN1484/MUM/2007 | 2007-08-02 | ||
IN1487MU2007 | 2007-08-02 | ||
IN1486/MUM/2007 | 2007-08-02 | ||
IN1485/MUM/2007 | 2007-08-02 | ||
IN1488MU2007 | 2007-08-02 | ||
IN600MU2008 | 2008-03-24 | ||
IN600/MUM/2008 | 2008-03-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009016608A2 WO2009016608A2 (en) | 2009-02-05 |
WO2009016608A3 true WO2009016608A3 (en) | 2009-05-28 |
Family
ID=40174794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2008/053091 WO2009016608A2 (en) | 2007-08-02 | 2008-08-01 | Pharmaceutical compositions of fenofibrate |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP2190415A2 (en) |
WO (1) | WO2009016608A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2865371B1 (en) * | 2013-10-22 | 2016-08-10 | Disphar International B.V. | Fast dissolving granules |
JP6787389B2 (en) | 2016-02-26 | 2020-11-18 | 株式会社ニコン | Detection device, detection system, detection method, information processing device, and processing program |
CN107126420A (en) * | 2017-05-09 | 2017-09-05 | 上海信谊万象药业股份有限公司 | A kind of high-dissolution fenofibrate and preparation method thereof |
CN107469091B (en) * | 2017-07-25 | 2020-09-22 | 广东省药品检验所(广东省药品质量研究所、广东省口岸药品检验所) | Magnetic fenofibrate-cyclodextrin inclusion compound |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040005339A1 (en) * | 2002-06-28 | 2004-01-08 | Shojaei Amir H. | Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability |
US20040157797A1 (en) * | 2003-02-03 | 2004-08-12 | Rong-Kun Chang | Drug formulation and delivery using crystalline methylated cyclodextrins |
WO2005034920A1 (en) * | 2003-10-10 | 2005-04-21 | Lifecycle Pharma A/S | A solid dosage form comprising a fibrate |
US20050096391A1 (en) * | 2003-10-10 | 2005-05-05 | Per Holm | Compositions comprising fenofibrate and rosuvastatin |
WO2006037348A1 (en) * | 2004-10-01 | 2006-04-13 | Lifecycle Pharma A/S | Pharmaceutical compositions comprising fenofibrate and a statin |
EP1707197A1 (en) * | 2005-03-30 | 2006-10-04 | Teva Pharmaceutical Industries Ltd. | Formulations containing fenofibrate and a surfactant mixture |
-
2008
- 2008-08-01 EP EP08789518A patent/EP2190415A2/en not_active Withdrawn
- 2008-08-01 WO PCT/IB2008/053091 patent/WO2009016608A2/en active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040005339A1 (en) * | 2002-06-28 | 2004-01-08 | Shojaei Amir H. | Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability |
WO2004002414A2 (en) * | 2002-06-28 | 2004-01-08 | Shire Laboratories Inc. | Self-emulsifying formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability and/or reduced food effect |
US20040157797A1 (en) * | 2003-02-03 | 2004-08-12 | Rong-Kun Chang | Drug formulation and delivery using crystalline methylated cyclodextrins |
WO2005034920A1 (en) * | 2003-10-10 | 2005-04-21 | Lifecycle Pharma A/S | A solid dosage form comprising a fibrate |
US20050096391A1 (en) * | 2003-10-10 | 2005-05-05 | Per Holm | Compositions comprising fenofibrate and rosuvastatin |
WO2006037348A1 (en) * | 2004-10-01 | 2006-04-13 | Lifecycle Pharma A/S | Pharmaceutical compositions comprising fenofibrate and a statin |
EP1707197A1 (en) * | 2005-03-30 | 2006-10-04 | Teva Pharmaceutical Industries Ltd. | Formulations containing fenofibrate and a surfactant mixture |
Non-Patent Citations (3)
Title |
---|
AIGNER Z ET AL: "INCREASING THE SOLUBILITY CHARACTERISTICS OF FENOFIBRATE WITH CYCLODEXTRIN", JOURNAL OF INCLUSION PHENOMENA AND MOLECULAR RECOGNITION INCHEMISTRY, KLUWER, DORDRECHT, NL, vol. 20, 1 January 1995 (1995-01-01), pages 241 - 252, XP009041938, ISSN: 0923-0750 * |
PALMIERI G F ET AL: "INCLUSION COMPLEXATION OF FENOFIBRATE WITH BETA-CYCLODEXTRIN AND HYDROXYPROPYL-BETA-CYCLODEXTRIN. EVALUATION OF INTERACTIONS IN SOLUTION AND SOLID COMPLEX CHARACTERIZATION", SCIENCES TECHNIQUES ET PRATIQUES STP PHARMA SCIENCES, PARIS, FR, vol. 7, no. 2, 1 January 1997 (1997-01-01), pages 174 - 181, XP009041885, ISSN: 1157-1489 * |
SHEU ET AL: "Characterization and dissolution of fenofibrate solid dispersion systems", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER BV, NL, vol. 103, no. 2, 1 January 1994 (1994-01-01), pages 137 - 146, XP002091325, ISSN: 0378-5173 * |
Also Published As
Publication number | Publication date |
---|---|
WO2009016608A2 (en) | 2009-02-05 |
EP2190415A2 (en) | 2010-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011077043A3 (en) | Phenol derivatives and pharmaceutical or cosmetic use thereof | |
AU2013257508A1 (en) | Pharmaceutical compositions | |
WO2007109605A3 (en) | Pharmaceutical compositions | |
WO2008021368A3 (en) | Compositions and methods for neuroprotection | |
WO2007135527A3 (en) | Benzimidazolyl compounds | |
WO2011069063A3 (en) | Multicyclic compounds and methods of use thereof | |
WO2007086001A3 (en) | Novel pyridine derivatives | |
WO2008049116A3 (en) | Substituted indoles | |
WO2012042371A3 (en) | Pharmaceutical composition | |
AU2007299727A8 (en) | Self preserved aqueous pharmaceutical compositions | |
WO2009121039A3 (en) | Administration of benzodiazepine compositions | |
WO2009135646A3 (en) | Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale | |
WO2009091898A3 (en) | 6-and 7-amino isoquinoline compounds and methods for making and using the same | |
WO2007139871A3 (en) | Methods and materials for making simvastatin and related compounds | |
WO2008070268A3 (en) | Pharmaceutical compositions | |
WO2008017346A3 (en) | Ascorbic acid derivatives, use thereof for the functionalization of matrices | |
WO2009115084A3 (en) | Pyrrolopyrimidine derivatives, and use thereof | |
WO2010049454A3 (en) | Antimicrobial composition from copepods | |
WO2008129501A3 (en) | Pharmaceutical compositions of duloxetine | |
WO2007057748A3 (en) | Use of colostrum for the prophylaxis of influenza syndromes | |
WO2008001201A3 (en) | Pharmaceutical compositions of clopidogrel | |
WO2010049449A3 (en) | Novel salts of sunitinib | |
WO2008088779A3 (en) | Solid state forms of 5-azacytidine and processes for preparation thereof | |
WO2008154234A3 (en) | Extended release formulation of nevirapine | |
WO2009047794A3 (en) | Docetaxel injectable composition, being absolutely free of ethanol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008789518 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12671832 Country of ref document: US |